Regulatory Submission in Europe in Absence of Reference product [Regulatives / Guidelines]

posted by dshah – India/ United Kingdom, 2021-03-23 09:51 (215 d 21:31 ago) – Posting: # 22290
Views: 6,247

Hi Abhay Patil!
In absence of Innovator product in EU and UK market for FDC, you may have to do BE against individual drug substance innovator product. Please see Guideline on clinical development of fixed combination medicinal products.
Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,756 posts in 4,548 threads, 1,544 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Monday 08:22 CEST (Europe/Vienna)

The plural of anecdote is data.    Raymond Wolfinger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5